Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer

British Journal of Surgery

Volumn 99, Issue 2, 2012, Pages 226-231

  Andersson, Y ^a   De Boniface, J ^b   Jonsson P E ^c   Ingvar, C ^d   Liljegren, G ^e   Bergkvist, L ^a,f   Frisell, J ^b  

^a CENTRAL HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855670432     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7820     Document Type: Article

References (25)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL,. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-398.
2. Krag DN, Weaver DL, Alex JC, Fairbank JT,. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
3. Nieweg OE, Jansen L, Valdes Olmos RA, Rutgers EJ, Peterse JL, Hoefnagel KA, et al., Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999; 26 (Suppl): S11-S16. (Pubitemid 29171613)
4. Bergkvist L, Frisell J,; Swedish Breast Cancer Group; Swedish Society of Breast Surgeons. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 2005; 92: 1221-1224. (Pubitemid 41475230)
5. Kuijt GP, Roumen RM,. Second thoughts on sentinel lymph node biopsy in node-negative breast cancer. Br J Surg 2008; 95: 310-311.
6. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al., GIVOM Trialists. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008; 247: 207-213. (Pubitemid 351156760)
7. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al., Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11: 927-933.
8. Pepels MJ, Vestjens JH, de Boer M, Smidt M, van Diest PJ, Borm GF, et al., Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat 2011; 125: 301-313.
9. van der Ploeg IM, Nieweg OE, van Rijk MC, Valdés Olmos RA, Kroon BB,. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008; 34: 1277-1284.
10. Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al., Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010; 251: 595-600.
11. de Kanter AY, Menke-Pluymers MM, Wouters MW, Burgmans I, van Geel AN, Eggermont AM,. 5-Year follow-up of sentinel node negative breast cancer patients. Eur J Surg Oncol 2006; 32: 282-286.
12. Kim HJ, Son BH, Lim WS, Seo JY, Koh BS, Lee JW, et al., Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up. Ann Surg Oncol 2010; 17: 2126-2131.
13. Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, et al., Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 2009; 45: 1381-1388.
14. Bergkvist L, de Boniface J, Jonsson PE, Ingvar C, Liljegren G, Frisell J,; Swedish Society of Breast Surgeons. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg 2008; 247: 150-156.
15. Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, et al., Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 2010; 17: 552-557.
16. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al., The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004; 240: 462-468.
17. Poletti P, Fenaroli P, Milesi A, Paludetti A, Mangiarotti S, Virotta G, et al., Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol 2008; 19: 1842-1846.
18. Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ,. Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 2005; 12: 29-33. (Pubitemid 40486638)
19. Swenson KK, Mahipal A, Nissen MJ, Tuttle TM, Heaton K, Lally RM, et al., Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 2005; 104: 1834-1839. (Pubitemid 41513165)
20. van der Ploeg IM, Kroon BB, Antonini N, Valdés Olmos RA, Rutgers EJ, Nieweg OE,. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol 2008; 15: 1025-1031.
21. Fredriksson I, Liljegren G, Arnesson LG, Emdin SO, Palm-Sjovall M, Fornander T, et al., Consequences of axillary recurrence after conservative breast surgery. Br J Surg 2002; 89: 902-908. (Pubitemid 34779576)
22. Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, et al., Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol 2010; 28: 3929-3936.
23. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, et al.,; American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007; 25: 3657-3663. (Pubitemid 47372604)
24. Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM,. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 2007; 33: 832-837. (Pubitemid 47279045)
25. Konstantiniuk P, Schrenk P, Reitsamer R, Koeberle-Wuehrer R, Tausch C, Roka S, et al., A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer. Breast 2007; 16: 520-526. (Pubitemid 47491609)